The world urgently needs 20 billion doses of a vaccine that will protect global citizens against the coronavirus. States are throwing huge sums of public money at the race to beat Covid-19, but who will get there first? Will Big Pharma focus on private profit? Will vaccine nationalism prevail, or will the patent be shared to create a low-cost global supply?
May 2020
Público, Portugal
Il Fatto Quotidiano, Italy
Falter, Austria
Republik, Switzerland
Der Tagesspiegel, Germany
Newsweek Poland, Poland
Basta!, France, Basta!
NRK, Norway
NRK, Norway
Stavanger Aftenblad, Norway
Baricada Bulgaria, Bulgaria
Baricada Bulgaria, Bulgaria
Gazeta Wyborcza, Poland
Público, Portugal
EfSyn, Greece
EUobserver, Belgium
Klassekampen, Norway
Il Fatto Quotidiano, Italy
Público, Portugal
Der Tagesspiegel, Germany
EUobserver, Belgium
taz, Germany
Il Fatto Quotidiano, Italy
Público, Portugal
EfSyn, Greece